AFI's 10 Top 10

Unlock Potential, Award Winning Hiring Program Aimed at Preventing Incarceration, Announces Regional Partnership with Virgin Hotels

Retrieved on: 
Tuesday, February 7, 2023
Justice, Equity, Virgin Unite, AFI's 10 Top 10, JPMorgan Chase, Work, Diversity, Virgin Hotels, Social mobility, Club, Partnership, Ben & Jerry's, Sam's Club, Delta Air Lines, Greyston Bakery, UP, Walmart, Project Management Institute, Bermingham, Employment, Ageing, Nursing

Virgin Hotels has joined Unlock Potential (UP), a hiring program to provide career opportunities for at-risk youth.

Key Points: 
  • Virgin Hotels has joined Unlock Potential (UP), a hiring program to provide career opportunities for at-risk youth.
  • "Through Unlock Potential, we can help create employment pathways for at-risk young adults that will strengthen our business and help end the prison pipeline."
  • UP companies are committed to advancing equity and social mobility, disrupting the poverty-to-prison pipeline, and inclusively growing their workforces.
  • The program was recently named a Top 10 Most Influential Project for Diversity, Equity & Inclusion by Project Management Institute.

First SyncAR for Spine Surgery in the World Performed at Hoag

Retrieved on: 
Wednesday, December 7, 2022
Magnet, Hoag (health network), Patient, Physician, Heart, Culture, Asa, CT, AR, OC, American Nurses Credentialing Center, Spine, ANCC, Anatomy, MRI, Cancer, Neuroscience, AFI's 10 Top 10, X-ray, Hospital, Neurosurgery, FDA, 3D, Robotics, News, Surgeon, Pathology, Multimedia, Health, UPMC, Elective surgery, Pharmaceutical industry, Medicine, Human skull symbolism

NEWPORT BEACH, Calif., Dec. 7, 2022 /PRNewswire/ -- Hoag's innovative spine team has performed the first spinal fusion surgery utilizing the recently FDA-cleared augmented reality (SyncAR) surgical navigator for Spine, co-developed by neurosurgeons from Hoag's Pickup Family Neurosciences Institute and medical visualization platform leader Surgical Theater.

Key Points: 
  • SyncAR for Spine utiizes 3D virtual reconstructions of CT and MRI images to enable detailed visualization of anatomic structures as well as the surgical tools and hardware.
  • Hoag's neurosurgeons have already studied and published the benefits of SyncAR technology in the lab, demonstrating an improved accuracy of >99% for screw placement in the spine.
  • SyncAR for Spine subsequently received FDA clearance in September 2022 paving the way for its utilization in the operating room to help real people.
  • "SyncAR for Spine is allowing not only enhanced navigation in the operating room, it is enabling more enlightening and informed pre-operative conversations with our patients.

First FDA-Approved Molecular Targeted Therapy for Metastatic Prostate Cancer Now Available at Hoag Family Cancer Institute

Retrieved on: 
Tuesday, March 29, 2022
Neuroscience, AFI's 10 Top 10, Radiation, Heart, Nuclear medicine, Therapy, Mental health, Transport, Clinical trial, Patient, Multimedia, ANCC, Prostate, Survival, Breast, Research, Multiple myeloma, Program, Hospital, PSMA, Radiology, Memorial Sloan Kettering Cancer Center, Cancer, National Institutes of Health, Neoplasm, Man, Health, Molecular medicine, American Nurses Credentialing Center, NIH, National, Prostate cancer, American College, Melanoma, Molecular imaging, R01, Isotope, FDA, Breast cancer, Education, Lung cancer, Elective surgery, Pharmaceutical industry, Medical imaging

The Hoag Family Cancer Institute also offers a growing number of additional molecular imaging and therapy agents, both FDA approved and on clinical trials, for patients with prostate, breast, myeloma and melanoma and lung malignancies.

Key Points: 
  • The Hoag Family Cancer Institute also offers a growing number of additional molecular imaging and therapy agents, both FDA approved and on clinical trials, for patients with prostate, breast, myeloma and melanoma and lung malignancies.
  • Hoag's Molecular Imaging & Therapy program was the first in Orange County to offer PSMA-targeted radiotherapy to patients with metastatic prostate cancer in clinical trials and now offers access to this newly FDA-approved therapy to patients.
  • "Hoag is at the tip of the spear, offering the most advanced therapies for patients with metastatic prostate cancer, such as Pluvicto," Dr. Ulaner said.
  • Through its robust Molecular Imaging & Therapy clinical trial offerings, Hoag has extensive experience using targeted molecular agents to diagnose and treat a variety of cancer types, including prostate cancer, breast cancer , melanoma , myeloma and lung cancer .

Hoag Opens Center for Advanced Visualization and Immersive Therapeutics

Retrieved on: 
Friday, October 1, 2021
DNV, Therapy, Human skull symbolism, U.S. News & World Report, Brain, Addiction medicine, US Global Development Lab, Transport, Patient, Virtual reality, Aneurysm, National Association of Epilepsy Centers, Hoag (health network), Center, No, Pain, AR, Mental health, Augmented reality, ANCC, Health, Stroke, American Heart Association, Multimedia, Pathology, Movement disorders, Physician, American Nurses Credentialing Center, Heart, Phobia, Neuro, Technology, Anatomy, Spine, Neuroscience, Elective surgery, Epilepsy, National Association, Memory, Cancer, Physiology, Hospital, Journal of Neurology, Neurosurgery, and Psychiatry, Multiple sclerosis, Education, XR, AFI's 10 Top 10, News, Pectus carinatum, VR, Nursing, Lists of diseases, Post-traumatic stress disorder, Research, Medicine

NEWPORT BEACH, Calif., Oct. 1, 2021 /PRNewswire/ --Already a nationally recognized leader in Experiential Reality (XR) technology, Hoag Memorial Hospital Presbyterian today announced the opening of the new Hoag Center for Advanced Visualization and Immersive Therapeutics inside Hoag's Pickup Family Neurosciences Institute Newport Beach campus.

Key Points: 
  • NEWPORT BEACH, Calif., Oct. 1, 2021 /PRNewswire/ --Already a nationally recognized leader in Experiential Reality (XR) technology, Hoag Memorial Hospital Presbyterian today announced the opening of the new Hoag Center for Advanced Visualization and Immersive Therapeutics inside Hoag's Pickup Family Neurosciences Institute Newport Beach campus.
  • Hoag will host the 2nd Annual Hoag Advances in Clinical Virtual Reality Symposium on Friday, October 1, 2021.
  • A preview of the new Hoag Center for Advanced Visualization and Immersive Therapeutics will be presented at this symposium.
  • Hoag has been recognized as a designated Level 4 Comprehensive Epilepsy Center by the National Association of Epilepsy Centers.